Mackenzie Financial Corp Increases Stock Position in Healthpeak Properties, Inc. (NYSE:DOC)

Mackenzie Financial Corp boosted its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 229.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 85,461 shares of the real estate investment trust's stock after buying an additional 59,524 shares during the period. Mackenzie Financial Corp's holdings in Healthpeak Properties were worth $1,732,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of DOC. Mizuho Bank Ltd. bought a new position in shares of Healthpeak Properties in the fourth quarter valued at approximately $28,000. Harvest Fund Management Co. Ltd bought a new position in Healthpeak Properties during the 4th quarter valued at $30,000. Covestor Ltd increased its position in shares of Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after purchasing an additional 1,152 shares during the period. Kestra Investment Management LLC acquired a new position in shares of Healthpeak Properties during the 4th quarter valued at $45,000. Finally, Kapitalo Investimentos Ltda bought a new stake in shares of Healthpeak Properties in the 4th quarter worth $46,000. Institutional investors and hedge funds own 93.57% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on DOC shares. Wedbush reduced their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Evercore ISI reduced their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Scotiabank dropped their price target on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a report on Monday, May 12th. Argus reiterated a "buy" rating and set a $25.00 price objective on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Finally, Robert W. Baird decreased their target price on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $23.27.

Insider Buying and Selling at Healthpeak Properties

In other Healthpeak Properties news, Director John T. Thomas acquired 4,200 shares of the company's stock in a transaction on Monday, April 28th. The shares were acquired at an average cost of $17.84 per share, with a total value of $74,928.00. Following the completion of the acquisition, the director now directly owns 813,566 shares in the company, valued at $14,514,017.44. This trade represents a 0.52% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Scott M. Brinker acquired 11,337 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was acquired at an average price of $17.68 per share, for a total transaction of $200,438.16. Following the transaction, the chief executive officer now directly owns 201,863 shares of the company's stock, valued at $3,568,937.84. This represents a 5.95% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 29,764 shares of company stock worth $521,909. 0.23% of the stock is currently owned by company insiders.

Healthpeak Properties Stock Down 0.2%

NYSE DOC traded down $0.04 during trading on Wednesday, hitting $17.11. The stock had a trading volume of 4,165,338 shares, compared to its average volume of 5,133,892. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. Healthpeak Properties, Inc. has a 12 month low of $16.64 and a 12 month high of $23.26. The company has a market capitalization of $11.89 billion, a PE ratio of 48.89, a P/E/G ratio of 2.17 and a beta of 1.05. The company's 50-day moving average price is $17.98 and its two-hundred day moving average price is $19.64.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The firm had revenue of $702.89 million for the quarter, compared to the consensus estimate of $690.76 million. During the same period in the previous year, the company earned $0.45 earnings per share. The company's quarterly revenue was up 15.9% on a year-over-year basis. As a group, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The company also recently declared a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were paid a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date was Monday, May 19th. Healthpeak Properties's payout ratio is 305.00%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.